Literature DB >> 1091895

Treatment of adenocarcinoma of the endometrium.

H W Jones.   

Abstract

The evidence concerning those factors related to prognosis in endometrial carcinoma has been reviewed and age, histologic differentiation of the tumor, depth of myometrial invasion and extent of disease have been found to be definitely correlated with survival. The development of different treatment methods has been traced and various modern treatment techniques have been discussed. On the basis of these prognostic indicators and reported experience with alternative methods of therapy, a plan of management for patients with endometrial carcinoma has been proposed. Although we believe this is a logical method with proven effectiveness, we wish to emphasize the importance of individualized therapy based on an understanding of the clinical-pathological findings.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091895     DOI: 10.1097/00006254-197503000-00001

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  5 in total

1.  [Endometrial cancer stages I and II--surgical treatment].

Authors:  O Käser
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

2.  Diagnosis and management of early carcinoma of the endometrium.

Authors:  L A Walton
Journal:  J Natl Med Assoc       Date:  1978-05       Impact factor: 1.798

3.  [Aminoacid-p-nitroanilides splitting activities in the mature human placenta (author's transl)].

Authors:  E Held
Journal:  Arch Gynakol       Date:  1977-07-08

4.  Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer.

Authors:  Farnaz Amouzegar Hashemi; Zakieh Vesgari Kiasari; Bita Kalaghchi; Mahdi Aghili; Soraya Gholami; Sepideh Mansouri; Sepand Moalej; Afsaneh Maddah Safaei
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

5.  The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma.

Authors:  Cem Dane; Sait Bakir
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.